Tyler-Stone Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Tyler-Stone Wealth Management's PFE Position: Q2 2025 in Review
Tyler-Stone Wealth Management reduced its Pfizer (PFE) stake by 2.5% in Q2 2025, selling an estimated $39.2K and leaving 64,772 shares worth $1.57M. The position accounts for 0.25% of the portfolio, ranked #77.
Tyler-Stone Wealth Management first reported a position in PFE in Q4 2021 and has held it in 14 quarters since. The position peaked at $3.18M in Q4 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Tyler-Stone Wealth Management held 64,772 shares of Pfizer worth $1.57M as of Q2 2025.
- Tyler-Stone Wealth Management sold 1,681 Pfizer shares in Q2 2025, an estimated $39.2K.
- Pfizer made up 0.25% of Tyler-Stone Wealth Management's portfolio in Q2 2025, its #77 holding.
- Tyler-Stone Wealth Management first reported a position in Pfizer in Q4 2021 and has held it in 14 quarters since.
- Tyler-Stone Wealth Management's Pfizer position peaked at $3.18M in Q4 2021.
- 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Tyler-Stone Wealth Management's 13F filing for Q2 2025, filed 18 Aug 2025.